Company
About us
Our Team
Discoveries
Programs
Publications
Selected
All
ES
Contact Us
Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis
Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis
The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders
Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis
Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease
Overexpression of inducible nitric oxide synthase and cyclooxygenase-2 in rat zinc-deficient lung: Involvement of a NF-kappaB dependent pathway
Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways
Galectin-1 as a potential cancer target
Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase
Galectins as modulators of tumour progression
NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes
